Search research articles
Contact Us
Filters
Showing results (101-110 of 128) with videos related to
Page
of 13
Sort By:
Focus (American Psychiatric Publishing)
|
January 31, 2020
Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms
Jimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Schizophrenia Research. Cognition
|
March 15, 2016
Insight and subjective measures of quality of life in chronic schizophrenia
Cynthia O Siu, Philip D Harvey, Ofer Agid, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
January 1, 2016
Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms
Jimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Schizophrenia Research
|
June 4, 2013
Risk of neutropenia in a clozapine-treated elderly population
Melanie D Guenette, Valerie Powell, Kimberly Johnston, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
June 17, 2016
What Is the Place of Clozapine in the Treatment of Early Psychosis in Canada?
Richard Williams, Ashok Malla, Marc-Andre Roy, et al.
Schizophrenia Research
|
December 5, 2014
Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia
Gagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, et al.
CNS Drugs
|
June 27, 2022
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
C U Correll, Ofer Agid, Benedicto Crespo-Facorro, et al.
CNS Drugs
|
August 17, 2022
Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
C U Correll, Ofer Agid, Benedicto Crespo-Facorro, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 24, 2024
Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, et al.
Schizophrenia Research
|
June 21, 2011
Effects of antipsychotics on D3 receptors: a clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO
Romina Mizrahi, Ofer Agid, Carol Borlido, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 128) with videos related to
Sort By:
Page
of 13
Focus (American Psychiatric Publishing)
|
January 31, 2020
Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms
Jimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Schizophrenia Research. Cognition
|
March 15, 2016
Insight and subjective measures of quality of life in chronic schizophrenia
Cynthia O Siu, Philip D Harvey, Ofer Agid, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
January 1, 2016
Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms
Jimmy Lee, Hiroyoshi Takeuchi, Gagan Fervaha, et al.
Schizophrenia Research
|
June 4, 2013
Risk of neutropenia in a clozapine-treated elderly population
Melanie D Guenette, Valerie Powell, Kimberly Johnston, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
June 17, 2016
What Is the Place of Clozapine in the Treatment of Early Psychosis in Canada?
Richard Williams, Ashok Malla, Marc-Andre Roy, et al.
Schizophrenia Research
|
December 5, 2014
Extrapyramidal symptoms and cognitive test performance in patients with schizophrenia
Gagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, et al.
CNS Drugs
|
June 27, 2022
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
C U Correll, Ofer Agid, Benedicto Crespo-Facorro, et al.
CNS Drugs
|
August 17, 2022
Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
C U Correll, Ofer Agid, Benedicto Crespo-Facorro, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 24, 2024
Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, et al.
Schizophrenia Research
|
June 21, 2011
Effects of antipsychotics on D3 receptors: a clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO
Romina Mizrahi, Ofer Agid, Carol Borlido, et al.
Page
of 13